Item 8.01 Other Events.
On January 27, 2021, PhaseBio Pharmaceuticals, Inc. issued a press release
entitled "PhaseBio Presents Data from Phase 1b/2a Trial of Pemziviptadil for the
Treatment of Pulmonary Arterial Hypertension at 15th Pulmonary Vascular Research
Institute Virtual World of Congress." The full text of the press release is
attached as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Press Release, dated January 27, 2021.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses